Capital Investment Advisory Services’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Capital Investment Advisory Services’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.5K	Hold	450	–	–	﹤0.01%	1017
2025 Q4	$14.8K	Hold	450	–	–	﹤0.01%	981
2025 Q3	$12.8K	Hold	450	–	–	﹤0.01%	942
2025 Q2	$11.5K	Hold	450	–	–	﹤0.01%	929
2025 Q1	$12.4K	Hold	450	–	–	﹤0.01%	859
2024 Q4	$12.1K	Hold	450	–	–	﹤0.01%	797
2024 Q3	$13K	Hold	450	–	–	﹤0.01%	835
2024 Q2	$12.3K	Hold	450	–	–	﹤0.01%	814
2024 Q1	$12.6K	Hold	450	–	–	﹤0.01%	806
2023 Q4	$12K	Buy	+450	New	+$11.3K	﹤0.01%	819

Other funds holding FTXH

LPL Financial San Diego, California $376B AUM 19.32% 1-Year Est. Return

Truist Financial

Truist Financial Charlotte, North Carolina $74.1B AUM 21.09% 1-Year Est. Return

Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.28B AUM 27.63% 1-Year Est. Return

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return